Éva Mórocz

机构：Károli Gáspár University of the Reformed Church in Hungary

发表论文 11 篇 · 总被引 173 次 · h-index 4

代表论文

• SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer (2023 · Annals of Oncology · 被引 99)
• Targeted therapeutic options in early and metastatic NSCLC-overview (2024 · Pathology & Oncology Research · 被引 37)
• Sotorasib (960 mg or 240 mg) once daily in patients with previously treated KRAS G12C-mutated advanced NSCLC (2024 · European Journal of Cancer · 被引 18)
• VP4-2023: Sotorasib 960 mg versus 240 mg in pretreated KRAS G12C advanced NSCLC (2023 · Annals of Oncology · 被引 13)
• [Endobronchial ultrasonography]. (2002 · PubMed · 被引 3)
• Early-stage resectable non-small cell lung cancer in Hungary (2025 · Pathology & Oncology Research · 被引 2)